BCRX
BioCryst Pharmaceuticals Inc
Price:  
7.93 
USD
Volume:  
1,769,490.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Fair Value

-137.69 %
Upside

As of 2024-12-11, the Fair Value of BioCryst Pharmaceuticals Inc (BCRX) is -2.99 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.93 USD, the upside of BioCryst Pharmaceuticals Inc is -137.69%.

Note: valuation result may not be accurate due to the company's negative EPS.

7.93 USD
Stock Price
-2.99 USD
Fair Price
FAIR VALUE CALCULATION

BCRX Fair Value

Peter Lynch's formula is:

BCRX Fair Value
= Earnings Growth Rate x TTM EPS
BCRX Fair Value
= 5.00 x -0.60
BCRX Fair Value
= -2.99

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -108.90 -182.80 -184.10 -247.10 -226.54 -189.89
YoY growth -7.50% -67.86% -0.71% -34.22% 8.32% -20.39%

BCRX Fair Value - Key Data

Market Cap (mil) 1,642.54
P/E
Forward P/E
EPS -0.60
Avg earnings growth rate -20.39%
TTM earnings -123.82